
The increased use of combined targeted therapies for breast cancer is set to lift the market and improve progression-free disease …

Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …

Teva has announced that its Board of Directors has unanimously voted to re-elect Dr Phillip Frost as Chairman of the …
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

